Compare SCLX & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | LOAN |
|---|---|---|
| Founded | 2011 | 1989 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.9M | 50.4M |
| IPO Year | N/A | 1999 |
| Metric | SCLX | LOAN |
|---|---|---|
| Price | $6.82 | $4.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 41.1K | 32.8K |
| Earning Date | 04-10-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 9.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $8,666,307.00 |
| Revenue This Year | $122.52 | N/A |
| Revenue Next Year | $186.30 | N/A |
| P/E Ratio | ★ N/A | $40.55 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.95 | $4.13 |
| 52 Week High | $34.27 | $5.85 |
| Indicator | SCLX | LOAN |
|---|---|---|
| Relative Strength Index (RSI) | 45.53 | 48.11 |
| Support Level | $6.20 | $4.33 |
| Resistance Level | $7.77 | $4.52 |
| Average True Range (ATR) | 0.72 | 0.16 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 71.43 | 17.02 |
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.